St Louis Cancer Care

An independent community oncology practice committed to personalized care of our patients

[Patients Rising @patientsrising]

A federal program created to help low-income patients is showing up in an unexpected place: bankruptcy court.

A new Patients Rising report reviewed more than 900 bankruptcy filings across six states and found that nearly half listed debt owed to nonprofit hospitals participating in the 340B drug discount program. While the research doesn't suggest the program causes bankruptcy, it raises an important question: if hospitals receive federal discounts intended to support vulnerable patients, why are so many of those same hospitals appearing as creditors in medical bankruptcies?

Read what the data uncovered, why Patients Rising is calling for greater transparency and the reforms we believe could help ensure 340B savings reach the patients the program was designed to serve in a white paper we crated reviewing 903 filings in six states.

Read more here: https://t.co/H0bhRaiAho

[Community Oncology @oncologyCOA]

At #CommunityOncology practices nationwide, in-house pharmacies ensure patients get the treatment they need, when they need it. @StLCancerCare’s Carol Riley, RN, is one of many participating in COA’s national peer-to-peer network of pharmacists and pharmacy technicians.

[Patients Rising @patientsrising]

Michigan hospitals claim to serve the underserved, but the numbers tell a different story. The 340B program was designed to help low-income and uninsured patients get the medications they need, but over time, it’s become a revenue stream that operates with little oversight.

[St Louis Cancer Care @StLCancerCare]

Honored to share that all of our outstanding oncologists have once again been recognized on the St. Louis Magazine Top Doctors List for 2024! This marks the 22nd consecutive year our team at SLCC has been featured!

[Link to the magazine](https://t.co/0nYYXzUnHj)

[Community Oncology @oncologyCOA]

To Carol Riley of @StLCancerCare, the most important goal of #communityoncology is to provide the best care possible for every patient. Learn how COA helps Carol and her team achieve it. https://t.co/S5wsozsajd

[St Louis Cancer Care @StLCancerCare]

Read more about bispecific antibodies at SLCC here:

https://t.co/C8kxCr88xX

[St Louis Cancer Care @StLCancerCare]

Exciting News at SLCC! We’re thrilled to share an emerging and promising area of cancer treatment: Bispecific Antibodies (BsAbs)! These innovative therapies are revolutionizing cancer care, offering hope and new possibilities for our patients.

[Ted Okon @TedOkonCOA]

Bg 3 #PBM oligarchs & lobbyists are hopping mad at the @nytimes expose on #PBMs. This piece exposes what cancer patients facing delays, denial & higher costs have been dealing w/ for years.

@RebeccaDRobbins & @ReedAbelson did a great job.

https://t.co/LoeVXYFlz1

[St Louis Cancer Care @StLCancerCare]

Dr. Pillot representing SLCC at the ASCO conference in Chicago this weekend! ASCO, the American Society of Clinical Oncology, is where the latest breakthroughs in cancer treatment and research are showcased. We are committed to bringing the best care to our patients!

[St Louis Cancer Care @StLCancerCare]

Dr. Cuevas and our Nurse Practitioners Katy Klein and Danielle Mathis represented St. Louis Cancer Care at the ONCare Oncology College conference in Denver this past weekend! We are excited to bring back new insights on managing a private practice and enhancing patient care!

[St Louis Cancer Care @StLCancerCare]

EXCITING NEWS!!! According to the latest article from The ASCO Post, community oncology practices like SLCC are the preferred choice for cancer treatment over hospitals and academic centers. Discover why patients trust us for their care!

Read more here: https://t.co/hV2l7Wy8rc

[St Louis Cancer Care @StLCancerCare]

An educational and fun weekend in Denver at the ION conference! Woke up with an 80's themed workout with colleagues from across the country followed by lectures about the latest research in oncology!

[St Louis Cancer Care @StLCancerCare]

Our Practice manager, Carol Riley, was on the stage again! This past weekend, she was on a panel discussing 505b(2) drugs and their challenges at the ION Oncology Exchange Conference.

[St Louis Cancer Care @StLCancerCare]

We are totality in love with these eclipse views from the office this aftermoon! #SolarEclipse2024

[St Louis Cancer Care @StLCancerCare]

This is no ordinary Monday, it's Moon-day! #SolarEclipse2024

[St Louis Cancer Care @StLCancerCare]

Dr. Pillot and Carol Riley, our Practice Manager, attended @oncologyCOA this weekend. The meeting motto - Stronger Together! Community oncology practices across the country came together to network, learn and advocate for our patients back home!

[Drug Channels @DrugChannels]

Another #340B myth busted! #BecauseOf340B, #healthcare costs for self-insured employers & patients are $5.2B higher. #340B margins earned by covered entities displace #PBM rebates.

@IQVIA_global report==> https://t.co/q3ClDU7AI5

[Community Oncology @oncologyCOA]

A recent report from the Alliance for Integrity and Reform of 340B found that 85% of disproportionate share hospitals in the U.S. received more from 340B profit than they invested in charity care in 2022 - from @beckershr @maddymaeashley

https://t.co/uYaZHyVSVZ

[St Louis Cancer Care @StLCancerCare]

We are excited about the unveiling of ONCare Alliance!

This organization is a collaboration of 33 independent community oncology practices across the US aimed to support and ensure the strength of community oncology as we care for patients living with cancer.

[St Louis Cancer Care @StLCancerCare]

Congrats to Dr. Hildreth, Dr. Cuevas and Dr. Pillot for being named a Castle Connolly Top Doctor... AGAIN!! These doctors represent the top 7% of all U.S. practicing physicians. The doctors were peer-nominated for the commitment to our patients and delivering high-quality care.